PDF herunterladen
Nervenheilkunde 2023; 42(01/02): 8-20
DOI: 10.1055/a-1928-4776
Schwerpunkt

Die sechs häufigsten peripherenvestibulären Syndrome

The six most frequent peripheral vestibular syndromes
Michael Strupp
1   Neurologische Klinik und Deutsches Schwindel- und Gleichgewichtszentrum (DSGZ), Klinikum der Ludwig Maximilians Universität, München
,
Andreas Zwergal
1   Neurologische Klinik und Deutsches Schwindel- und Gleichgewichtszentrum (DSGZ), Klinikum der Ludwig Maximilians Universität, München
,
Nicolina Goldschagg
1   Neurologische Klinik und Deutsches Schwindel- und Gleichgewichtszentrum (DSGZ), Klinikum der Ludwig Maximilians Universität, München
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

ZUSAMMENFASSUNG

Periphere vestibuläre Syndrome beruhen auf einer Funktionsstörung des Labyrinths und/oder des Nervus vestibulocochlearis. Phänomenologisch und pathophysiologisch lassen sich 3 Formen klinisch unterscheiden: 1. Rezidivierende Schwindelepisoden mit je nach Ursache unterschiedlicher Dauer, unterschiedlichen Begleitsymptomen und Auslösern. Die zugrunde liegenden Erkrankungen sind der Benigne periphere paroxysmale Lagerungsschwindel, Morbus Menière, Vestibularisparoxysmie und das Syndrom der dritten mobilen Fenster. 2. Das akute vestibuläre Syndrom, bedingt durch eine akute vestibuläre Tonusdifferenz mit dem Leitsymptom heftiger langdauernder Drehschwindel: die akute unilaterale Vestibulopathie/Neuritis vestibularis. 3. Persistierender Schwankschwindel und Gangunsicherheit bedingt durch ein bilaterales vestibuläres Defizit: die bilaterale Vestibulopathie. Für alle diese Erkrankungen liegen Diagnosekriterien der Bárány-Society vor, die gleichermaßen wichtig sind für die klinische Praxis und für wissenschaftliche Studien. Für die Behandlung peripherer vestibulärer Syndrome werden in Abhängigkeit von der Ursache 5 Therapieprinzipien eingesetzt: 1. Sorgfältige Aufklärung des Patienten über Art und Ursache der Beschwerden und die Therapieeffekte; dies ist auch wichtig für die Compliance des Patienten. 2. Physikalisch-medizinische Behandlung: A) Bogengangspezifische Befreiungsmanöver: für den posterioren Kanal das SémontPlus-Manöver, das dem Sémont- und Epley- Manöver überlegen ist; für den horizontalen Kanal das modifizierte Roll-Manöver und für den anterioren Bogengang das modifizierte Yacovino-Manöver. B) Balancetraining bei sensorischen Defiziten (hohe Evidenz). 3. Symptomatische oder kausale medikamentöse Behandlung. Hier mangelt es weiterhin an placebokontrollierten Pharmakotherapiestudien, sodass die Evidenzlage niedrig ist und ein hoher klinischer Forschungsbedarf besteht. 4. Operative Maßnahmen, z. B. bei dem Syndrom der dritten mobilen Fenster. 5. Bei funktionellem Schwindel psychotherapeutische Verfahren.

ABSTRACT

Three forms of peripheral vestibular disorders, each with its typical symptoms and clinical signs, can be differentiated functionally, anatomically and pathophysiologically: 1. inadequate unilateral paroxysmal stimulation or rarely inhibition of the peripheral vestibular system, e. g., BPPV, Menière’s disease, vestibular paroxysmia or syndrome of the third mobile windows; 2. acute unilateral vestibulopathy leading to an acute vestibular tone imbalance manifesting as an acute peripheral vestibular syndrome; and 3. loss or impairment of function of the vestibular nerve and/or labyrinth: bilateral vestibulopathy. For all of these diseases, current diagnostic criteria by the Bárány-Society are available with a high clinical and scientific impact, also for clinical trials. The treatment depends on the underlying disease. It basically consists of 5 principles: 1. Explaining the symptoms and signs, pathophysiology, aetiology and treatment options to the patient; this is important for compliance, adherence and persistence. 2. Physical therapy: A) For BPPV specific liberatory maneuvers, depending on canal involved. Posterior canal: The new SémontPLUS maneuver is superior to the regular Sémont and Epley maneuvers; horizontal canal: the modified roll-maneuver; anterior canal the modified Yacovino-maneuver; 3. Symptomatic or causative drug therapy. There is still a deficit of placebo-controlled clinical trials so that the level of evidence for pharmacotherapy is most often low. 4. Surgery, mainly for the syndrome of the third mobile windows. 5. Psychotherapeutic measures for secondary functional dizziness.

Schlüsselwörter

Benigner peripherer paroxysmaler Lagerungsschwindel - akute unilaterale Vestibulopathie - Morbus Menière - bilaterale Vestibulopathie - Vestibularisparoxysmie - Syndrom der dritten mobilen Fenster

Key words

Benign paroxysmal positional vertigo - acute unilateral vestibulopathy - Meniere’s disease - bilateral vestibulopathy - vestibular paroxysmia - syndrome of the third mobile windows


Publikationsverlauf

Artikel online veröffentlicht:
13. Februar 2023

© 2023. Thieme. All rights reserved.

© Georg Thieme Verlag KG Stuttgart · New York
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Hulse R, Biesdorf A, Hormann K. et al Peripheral Vestibular Disorders: An Epidemiologic Survey in 70 Million Individuals. Otol Neurotol 2019; 40 (01) 88-95
    CrossrefPubMedGoogle Scholar
  • 2 Strupp M, Brandt T, Dieterich M.. Vertigo – Leitsymptom Schwindel. Heidelberg: Springer; 2022
    CrossrefGoogle Scholar
  • 3 Strupp M, Zwergal A.. Pharmacotherapy of peripheral vestibular disorders. The Senses. Amsterdam: Elsevier; 2021
    Google Scholar
  • 4 Neuhauser HK. The epidemiology of dizziness and vertigo. Handb Clin Neurol 2016; 137: 67-82
    CrossrefPubMedGoogle Scholar
  • 5 Bhattacharyya N, Gubbels SP, Schwartz SR. et al Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngol Head Neck Surg 2017; 156 (Suppl. 03) S1-S47
    CrossrefPubMedGoogle Scholar
  • 6 von Brevern M, Bertholon P, Brandt T. et al Benign paroxysmal positional vertigo: Diagnostic criteria. J Vestib Res 2015; 25 3–4 105-117
    CrossrefPubMedGoogle Scholar
  • 7 Hilton MP, Pinder DK. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev 2014; 12: CD003162
    CrossrefPubMedGoogle Scholar
  • 8 Sémont A, Freyss G, Vitte E. Curing the BPPV with a liberatory maneuver. Adv Otorhinolaryngol 1988; 42: 290-293
    CrossrefPubMedGoogle Scholar
  • 9 Obrist D, Nienhaus A, Zamaro E. et al Determinants for a Successful Sémont Maneuver: An In vitro Study with a Semicircular Canal Model. Front Neurol 2016; 07: 150
    CrossrefPubMedGoogle Scholar
  • 10 Strupp M, Goldschagg N, Vinck AS. et al BPPV: Comparison of the SémontPLUS With the Sémont Maneuver: A Prospective Randomized Trial. Front Neurol 2021; 12: 652573
    CrossrefPubMedGoogle Scholar
  • 11 Gebhart I, Götting C, Hool SL. et al Sémont Maneuver for Benign Paroxysmal Positional Vertigo Treatment: Moving in the Correct Plane Matters. Otol Neurotol 2021; 42 (03) e341-e347
    CrossrefPubMedGoogle Scholar
  • 12 Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg 1992; 107 (03) 399-404
    CrossrefPubMedGoogle Scholar
  • 13 Bremova T, Bayer O, Agrawal Y. et al Ocular VEMPs indicate repositioning of otoconia to the utricle after successful liberatory maneuvers in benign paroxysmal positioning vertigo. Acta Otolaryngol 2013; 133 (12) 1297-1303
    CrossrefPubMedGoogle Scholar
  • 14 Bhandari A, Bhandari R, Kingma H. et al Modified Interpretations of the Supine Roll Test in Horizontal Canal BPPV Based on Simulations: How the Initial Position of the Debris in the Canal and the Sequence of Testing Affects the Direction of the Nystagmus and the Diagnosis. Front Neurol 2022; 13: 881156
    CrossrefPubMedGoogle Scholar
  • 15 Zuma e Maia, Ramos BF, Cal R. et al Management of Lateral Semicircular Canal Benign Paroxysmal Positional Vertigo. Front Neurol 2020; 11: 1040
    CrossrefPubMedGoogle Scholar
  • 16 Bhandari A, Bhandari R, Kingma H. et al Three-dimensional simulations of six treatment maneuvers for horizontal canal benign paroxysmal positional vertigo canalithiasis. Eur J Neurol 2021; 28 (12) 4178-4183
    CrossrefPubMedGoogle Scholar
  • 17 Vannucchi P, Giannoni B, Pagnini P. Treatment of horizontal semicircular canal benign paroxysmal positional vertigo. J Vestib Res 1997; 07 (01) 1-6
    CrossrefGoogle Scholar
  • 18 Kim JS, Oh SY, Lee SH. et al Randomized clinical trial for apogeotropic horizontal canal benign paroxysmal positional vertigo. Neurology 2012; 78 (03) 159-166
    CrossrefPubMedGoogle Scholar
  • 19 Bhandari A, Bhandari R, Kingma H. et al Diagnostic and Therapeutic Maneuvers for Anterior Canal BPPV Canalithiasis: Three-Dimensional Simulations. Front Neurol 2021; 12: 740599
    CrossrefPubMedGoogle Scholar
  • 20 Lopez-Escamez JA, Carey J, Chung WH. et al Diagnostic criteria for Meniere’s disease. J Vestib Res 2015; 25 (01) 1-7
    CrossrefPubMedGoogle Scholar
  • 21 Rizk HG, Mehta NK, Qureshi U. et al Pathogenesis and etiology of Meniere’s disease: A scoping review of a century of evidence. JAMA Otolaryngol Head Neck Surg 2022; 148 (04) 360-368
    CrossrefPubMedGoogle Scholar
  • 22 van der Lubbe MFJA, Vaidyanathan A, Van R V. et al The “hype” of hydrops in classifying vestibular disorders: a narrative review. J Neurol 2020; 267 (Suppl. 01) 197-211
    CrossrefPubMedGoogle Scholar
  • 23 Adrion C, Fischer CS, Wagner J. et al Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 2016; 352: h6816
    CrossrefPubMedGoogle Scholar
  • 24 van Esch BF, Zaag-Loonen H, Bruintjes T. et al Interventions for Meniere’s disease: an umbrella systematic review. BMJ Evid Based Med 2022; 27 (04) 235-245
    CrossrefPubMedGoogle Scholar
  • 25 Zhang Y, Fu J, Lin H. et al The Clinical Outcomes After Intratympanic Gentamicin Injection to Treat Meniere’s Disease: A Meta-analysis. Otol Neurotol 2019; 40 (04) 419-429
    CrossrefPubMedGoogle Scholar
  • 26 Strupp M, Dlugaiczyk J, Ertl-Wagner BB. et al Vestibular Disorders. Dtsch Arztebl Int 2020; 117 (17) 300-310
    CrossrefPubMedGoogle Scholar
  • 27 Huppert D, Strupp M, Brandt T. Long-term course of Meniere’s disease revisited. Acta Otolaryngol 2010; 130 (06) 644-651
    CrossrefPubMedGoogle Scholar
  • 28 Brandt T, Dieterich M. Vestibular paroxysmia: vascular compression of the eighth nerve?. Lancet 1994; 343 8900 798-799
    CrossrefPubMedGoogle Scholar
  • 29 Sivarasan N, Touska P, Murdin L. et al MRI findings in vestibular paroxysmia – An observational study. J Vestib Res 2019; 29 2– 137-145
    CrossrefPubMedGoogle Scholar
  • 30 Teh CS, Noordiana SH, Shamini S. et al Vascular Loops: The Innocent Bystander for Vestibular Paroxysmia. Ann Otol Rhinol Laryngol 2021: 34894211037211
    Google Scholar
  • 31 Young AS, Jonker B, Welgampola MS. Vestibular paroxysmia presenting with irritative nystagmus. Neurology 2019; 92 (15) 723-724
    CrossrefPubMedGoogle Scholar
  • 32 Best C, Gawehn J, Kramer HH. et al MRI and neurophysiology in vestibular paroxysmia: contradiction and correlation. J Neurol Neurosurg Psychiatry 2010; 84 (12) 1349-1356
    CrossrefPubMedGoogle Scholar
  • 33 Strupp M, Dieterich M, Brandt T. et al Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia. Curr Treat Options Neurol 2016; 18 (07) 34
    CrossrefPubMedGoogle Scholar
  • 34 Bayer O, Bremova T, Strupp M. et al A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine. J Neurol 2018; 265 (02) 291-298
    CrossrefPubMedGoogle Scholar
  • 35 Strupp M, Elger C, Goldschagg N. Treatment of vestibular paroxysmia with lacosamide. Neurol Clin Pract 2019; 09 (06) 539-541
    CrossrefPubMedGoogle Scholar
  • 36 Moller MB, Moller AR, Jannetta PJ. et al Diagnosis and surgical treatment of disabling positional vertigo. J Neurosurg 1986; 64: 21-28
    CrossrefPubMedGoogle Scholar
  • 37 Minor LB, Solomon D, Zinreich JS. et al Sound- and/or pressure-induced vertigo due to bone dehiscence of the superior semicircular canal. Arch Otolaryngol Head Neck Surg 1998; 124 (03) 249-258
    CrossrefPubMedGoogle Scholar
  • 38 Ward BK, van de Berg R, Van R V. et al Superior semicircular canal dehiscence syndrome: Diagnostic criteria consensus document of the committee for the classification of vestibular disorders of the Barany Society. J Vestib Res 2021; 31 (03) 131-141
    CrossrefPubMedGoogle Scholar
  • 39 Walsh EM. Current management of superior semicircular canal dehiscence syndrome. Curr Opin Otolaryngol Head Neck Surg 2020; 28 (05) 340-345
    CrossrefPubMedGoogle Scholar
  • 40 Strupp M, Bisdorff A, Furman J. et al Acute unilateral vestibulopathy/vestibular neuritis: Diagnostic criteria. J Vestib Res 2022; 32 (05) 389-406
    CrossrefPubMedGoogle Scholar
  • 41 Strupp M, Fischer C, Hanss L. et al The takeaway Frenzel goggles: a Fresnel-based device. Neurology 2014; 83 (14) 1241-1245
    CrossrefPubMedGoogle Scholar
  • 42 Mantokoudis G, Wyss T, Zamaro E. et al Stroke Prediction Based on the Spontaneous Nystagmus Suppression Test in Dizzy Patients: A Diagnostic Accuracy Study. Neurology 2021; 97 (01) e42-e51
    CrossrefPubMedGoogle Scholar
  • 43 Manzari L, Princi AA, De AS. et al Clinical value of the video head impulse test in patients with vestibular neuritis: a systematic review. Eur Arch Otorhinolaryngol 2021; 278 (11) 4155-4167
    CrossrefPubMedGoogle Scholar
  • 44 Green KE, Gold DR. HINTS Examination in Acute Vestibular Neuritis: Do Not Look Too Hard for the Skew. J Neuroophthalmol 2021; 41 (04) e672-e678
    CrossrefPubMedGoogle Scholar
  • 45 Korda A, Zamaro E, Wagner F. et al Acute vestibular syndrome: is skew deviation a central sign?. J Neurol 2022; 269 (03) 1396-1403
    CrossrefPubMedGoogle Scholar
  • 46 Mantokoudis G, Korda A, Zee DS. et al Bruns’ nystagmus revisited: A sign of stroke in patients with the acute vestibular syndrome. Eur J Neurol 2021; 28 (09) 2971-2979
    CrossrefPubMedGoogle Scholar
  • 47 Strupp M, Magnusson M. Acute Unilateral Vestibulopathy. Neurol Clin 2015; 33 (03) 669-685
    CrossrefPubMedGoogle Scholar
  • 48 Rujescu D, Hartmann AM, Giegling I. et al Genome-Wide Association Study in Vestibular Neuritis: Involvement of the Host Factor for HSV-1 Replication. Front Neurol 2018; 09: 591
    CrossrefPubMedGoogle Scholar
  • 49 Rujescu D, Herrling M, Hartmann AM. et al High-risk Allele for Herpes Labialis Severity at the IFNL3/4 Locus is Associated With Vestibular Neuritis. Front Neurol 2020; 11: 570638
    CrossrefPubMedGoogle Scholar
  • 50 Strupp M, Zingler VC, Arbusow V. et al Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004; 351 (04) 354-361
    CrossrefPubMedGoogle Scholar
  • 51 Sjogren J, Magnusson M, Tjernstrom F. et al Steroids for Acute Vestibular Neuronitis-the Earlier the Treatment, the Better the Outcome?. Otol Neurotol 2019; 40 (03) 372-374
    CrossrefPubMedGoogle Scholar
  • 52 Leong KJ, Lau T, Stewart V. et al Systematic Review and Meta-analysis: Effectiveness of Corticosteroids in Treating Adults With Acute Vestibular Neuritis. Otolaryngol Head Neck Surg 2021: 194599820982910
    Google Scholar
  • 53 Kim G, Seo JH, Lee SJ. et al Therapeutic effect of steroids on vestibular neuritis: Systematic review and meta-analysis. Clin Otolaryngol 2022; 47 (01) 34-43
    CrossrefPubMedGoogle Scholar
  • 54 Dunlap PM, Holmberg JM, Whitney SL. Vestibular rehabilitation: advances in peripheral and central vestibular disorders. Curr Opin Neurol 2019; 32 (01) 137-144
    CrossrefPubMedGoogle Scholar
  • 55 McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev 2015; 01: CD005397
    Google Scholar
  • 56 Feil K, Strobl R, Schindler A. et al What Is Behind Cerebellar Vertigo and Dizziness?. Cerebellum 2019; 18 (03) 320-332
    Google Scholar
  • 57 Strupp M, Kim JS, Murofushi T. et al Bilateral vestibulopathy: Diagnostic criteria Consensus document of the Classification Committee of the Barany Society. J Vestib Res 2017; 27 (04) 177-189
    CrossrefPubMedGoogle Scholar
  • 58 Kim JS, Kim HJ. Bilateral vestibulopathy: the causes, diagnosis, and treatments. Curr Opin Neurol 2022; 35 (01) 98-106
    CrossrefPubMedGoogle Scholar
  • 59 Lucieer F, Vonk P, Guinand N. et al Bilateral Vestibular Hypofunction: Insights in Etiologies, Clinical Subtypes, and Diagnostics. Front Neurol 2016; 07: 26
    CrossrefPubMedGoogle Scholar
  • 60 ingler VC, Cnyrim C, Jahn K. et al Causative factors and epidemiology of bilateral vestibulopathy in 255 patients. Ann Neurol 2007; 61 (06) 524-532
    CrossrefPubMedGoogle Scholar
  • 61 Chow MR, Ayiotis AI, Schoo DP. et al Posture, Gait, Quality of Life, and Hearing with a Vestibular Implant. N Engl J Med 2021; 384 (06) 521-532
    CrossrefPubMedGoogle Scholar
  • 62 Strupp, et al Abstract, FP1127, Barany Society Meeting, Madrid. 2022
    PubMedGoogle Scholar
  • 63 Strupp, et al Abstract, FP1126, Barany Society Meeting, Madrid. 2022
    PubMedGoogle Scholar